ABSTRACT
BACKGROUND AND OBJECTIVE: Isoflurane has been used as an inhaled anaesthetic for nearly 30 years. Isoflurane inhalation during anaesthesia also produces an anti-nociceptive effect. Whether this occurs at the spinal or supraspinal level remains unknown. With a novel type of liquid isoflurane, the present study examined the effects of intrathecal isoflurane on the nociceptive response and Fos expression in the rat spinal cord. METHODS: Thirty-six rats were randomly assigned to three groups as follows: group A (n = 6), intrathecal physiological saline 50 µl kg⻹; and group B and C (n = 6 each), intrathecal isoflurane at doses of 25 µl kg⻹ or 50 µl kg⻹, respectively. Noxious thermal (Hargreaves test), mechanical (von Frey test) and chemical (formalin 5%, 50 µl) stimuli were applied to a hind paw after intrathecal isoflurane injection to study its anti-nociceptive effect. In addition, the expression of Fos protein and c-fos mRNA in the spinal dorsal horns was detected by immunohistochemistry and real-time reverse transcriptase PCR, respectively. RESULTS: Compared with the physiological saline control, intrathecal isoflurane significantly suppressed spontaneous paw flinches in rats induced by formalin injection and paw withdrawal induced by thermal and mechanical stimuli in a dose-dependent manner. Immunohistochemistry and real-time reverse transcriptase PCR revealed that isoflurane administration inhibited formalin injection-induced c-fos expression in the spinal cord. CONCLUSIONS: These data suggest that isoflurane can exert anti-nociceptive effects at the spinal level by preventing neuronal activation.
